NOS3 prevents MMP-9, and MMP-13 induced extracellular matrix proteolytic degradation through specific microRNA-targeted expression of extracellular matrix metalloproteinase inducer in hypertension-related atherosclerosis.

Authors:
Ramírez-Carracedo R; Hernández I; Moreno-Gómez-Toledano R; Díez-Mata J; Tesoro L and 7 more

Journal:
J Hypertens

Publication Year: 2024

DOI:
10.1097/HJH.0000000000003679

PMCID:
PMC10906209

PMID:
38406874

View on PubMed View on PMC View Publisher

Journal Information

Journal Title: J Hypertens

Detailed journal information not available.

Publication Details

Subject Category: Peripheral Vascular Disease

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score

3/6

50.0% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Code Sharing

COI Disclosure

Evidence found in paper:

"Conflicts of interest There are no conflicts of interest."

Funding Disclosure

Evidence found in paper:

"Financial support: this research was funded by Carlos Zaragoza ‘Instituto de Salud Carlos III, PI14/02022 co-financed by the European Development Regional Fund A way to achieve Europe (ERDF)’ and ‘Universidad Francisco de Vitoria, Grant number 2019’."

Protocol Registration

Open Access

Paper is freely available to read

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025